European Council adopts common position on FP7

Seventh Framework ProgrammeThe European Council adopted a common position on the Seventh Framework Programme (FP7) at a Competitiveness Council meeting, held on 25 September in Brussels. Agreement on FP7 should now be reached under the co-decision procedure, assuming the European Parliament responds positively in its second reading.

The political decision was made on 24 July during the previous Competitiveness Council, also held in Brussels. In the July meeting, all but the Austrian, Lithuanian, Maltese, Polish and Slovak delegations voted in favour, carrying FP7 through by a substantial qualified majority.

The political agreement came thanks to intervention by the Presidency, where rules for stem cell research were clarified, to the satisfaction of most delegations.

FP7 has been drawn up to give priority to four specific areas:

  • Cooperation - collaborative research;
  • Ideas - including the establishment of the European Research Council (ERC);
  • People - human resources;
  • Capacities.

FP7 is expected to be easier to negotiate for participants, offer more opportunities for research and researchers, and bring science and society closer.

FP7, including Euratom, has a budget of €50.4 billion.

For further information, please read Council Conclusions (.pdf file, 240.54 KB).

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg – http://cordis.europa.eu.int. Access to CORDIS is currently available free-of-charge.

Most Popular Now

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...

AI Body Composition Measurements can Pre…

Adiposity - or the accumulation of excess fat in the body - is a known driver of cardiometabolic diseases such as heart disease, stroke, type 2 diabetes, and kidney disease...